/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR
DISSEMINATION IN THE UNITED
VANCOUVER, BC, Jan. 14, 2021 /CNW/ - Numinus Wellness Inc.
("Numinus" or the "Company") (TSXV: NUMI), a company
creating an ecosystem of health solutions centered around
developing and supporting the safe, evidence-based, accessible use
of psychedelic-assisted psychotherapies, announces that it has
granted 1,975,000 incentive stock options (the "Options") to
directors, officers and employees of the Company, which are subject
to regulatory approval.
Of the 1,975,000 Options granted, 1,800,000 were issued to
directors and officers of Numinus, which have an exercise price of
$1.16 per common share and are
exercisable until January 13, 2023.
The 175,000 Options issued to employees were granted earlier this
month, have an exercise price of $1.09 and are exercisable until January 5, 2023.
The Company's Stock Option Plan allows for the issuance of up to
10% of issued and outstanding share capital in the form of
incentive stock options. As the result of the above grants, the
Company has 7,604,500 options issued, representing 4.74% of the
issued and outstanding share capital.
Numinus Wellness Inc. (TSXV: NUMI) is a mental
health and wellness company creating an ecosystem of solutions
centred around safe, evidence-based, accessible
psychedelic-assisted psychotherapy to help people heal and be
Numinus Health is dedicated to delivering innovative
treatments to address physical, mental, and emotional health,
through clinics and virtual services.
Numinus R&D is conducting implementation science
and leveraging partnerships to beta-test and refine optimal models
of psychedelic-assisted psychotherapy delivery, setting the stage
for approved routine use in mental health and wellness care.
Numinus Bioscience is focused on developing testing
methods and effective formulas for the evolving psychedelics space.
Health Canada licences, scientific
expertise, and new technologies facilitate ongoing innovation, and
high-throughput contract services generate established revenue.
Learn more at numinus.ca, and follow us
on Facebook, Twitter, and Instagram.
This news release contains "forward-looking information"
within the meaning of applicable securities laws, including but not
limited to statements relating to the use of proceeds from the
Offering. Although the Company believes, in light of the experience
of its officers and directors, current conditions and expected
future developments and other factors that have been considered
appropriate, that the expectations reflected in this
forward-looking information are reasonable, undue reliance should
not be placed on them because the Company can give no assurance
that they will prove to be correct. Actual results and developments
may differ materially from those contemplated by these statements.
The statements in this press release are made as of the date of
this release and the Company assumes no responsibility to update
them or revise them to reflect new events or circumstances other
than as required by applicable securities laws. The Company
undertakes no obligation to comment on analyses, expectations or
statements made by third-parties in respect of the Company, its
subsidiaries, their securities, or their respective financial or
operating results (as applicable).
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
ON BEHALF OF THE BOARD OF NUMINUS WELLNESS INC.
President, Chief Executive Officer and Chair
SOURCE Numinus Wellness Inc.